The human polyomavirus, JCV, uses serotonin receptors to infect cells
about
Human polyomavirus reactivation: disease pathogenesis and treatment approachesp90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling.Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainProgressive multifocal leukoencephalopathy: current treatment options and future perspectivesMechanisms of BK virus infection of renal cells and therapeutic implicationsJC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?Progressive multifocal leukoencephalopathy: clinical and molecular aspectsIn silico molecular comparisons of C. elegans and mammalian pharmacology identify distinct targets that regulate feedingA cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycleStructural basis of GM1 ganglioside recognition by simian virus 40Structure-Function Analysis of the Human JC Polyomavirus Establishes the LSTc Pentasaccharide as a Functional Receptor MotifProgressive Multifocal Leukoencephalopathy-Associated Mutations in the JC Polyomavirus Capsid Disrupt Lactoseries Tetrasaccharide c BindingIn Vitro and In Vivo Models for the Study of Human Polyomavirus InfectionProgressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarateProgressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.Treatment of Progressive Multifocal Leukoencephalopathy With Mirtazapine.The changing landscape of progressive multifocal leukoencephalopathy.Suppressive effect of PARP-1 inhibitor on JC virus replication in vitro.Virus trafficking - learning from single-virus trackingProgressive multifocal leukoencephalopathy: a rare infectious complication following allogeneic hematopoietic cell transplantation (HCT).Finding new tricks for old drugs: an efficient route for public-sector drug discovery.Progressive multifocal leukoencephalopathy in HIV-1 infection.Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppressionMetabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry.Involvement of cytoskeletal components in BK virus infectious entry.Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.Role of N-linked glycosylation of the 5-HT2A receptor in JC virus infection.PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis.Inhibition of large T antigen ATPase activity as a potential strategy to develop anti-polyomavirus JC drugsSmall tumor antigen of polyomaviruses: role in viral life cycle and cell transformationSchizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii.Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy.Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment optionPulmonary tumors associated with the JC virus T-antigen in a transgenic mouse model.Determinants of survival in progressive multifocal leukoencephalopathyJC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection.Invasion of host cells by JC virus identifies a novel role for caveolae in endosomal sorting of noncaveolar ligands.An animal model for progressive multifocal leukoencephalopathy
P2860
Q21285083-8C416EEF-605B-4610-9DAA-A54F639597A8Q24545327-E57B34BA-F220-44CB-B754-04385AE90B68Q24619923-A65FEBF8-2316-4344-B68F-60373146F230Q26776236-9FEF3DF0-3D37-4EF4-A96F-583CD4E1365BQ26795732-6B29BE73-1353-4315-9A38-1336F90C5E73Q26852060-AC57DD0F-3D97-4595-960F-75D933D85384Q26858968-A73089DD-3117-4BBA-AD51-CFFB6DD5D68CQ27316596-CC4A5E79-C7D3-4080-ABD0-9177CAF09D13Q27491288-26209C38-D28C-472D-8E39-2CE25E321FDDQ27650118-6D2B8ED5-E0BB-4608-9059-235F30E4C21EQ27665095-07BF9291-D8A2-46A0-9A93-DA581E21714BQ27678593-0F784F4D-8AE0-40D0-946E-ECCB8DFED0A2Q28074684-5D5F46D7-13E7-451B-B3BD-0275A79277F7Q28083338-65D29674-2F6D-4C27-9D3F-900B49794350Q30245002-BA2B9A4C-570D-452A-B447-3709C585EC83Q30249052-34E00825-A308-415F-B31E-25636C557260Q30403035-9336FB56-EC14-4CD5-864F-4DD70F8A5D38Q30422440-1D2A9839-9E43-422B-AC6A-3599D82F6812Q30490068-DDD5FB72-AEDC-4A0C-A56A-EA0EE0CDCA07Q30676296-CB8CCC5F-B97C-4881-A5C2-7668F86A120BQ33229063-DD480260-4398-4E76-ADD5-8983DF14AF19Q33506561-029268C6-C7BA-40D9-8ECA-C5D9D2B3BB2CQ33510514-B0AF8D2F-06C2-4197-B52B-3C4C41AF53E5Q33605681-A1E580C7-DBD1-41F9-930B-B016AE9F9AE2Q33893285-F5031CA3-C13E-4EF5-838C-936DDEF25D45Q33987448-FB9DD7F5-1FEA-45F0-BFC9-3881DB506AA7Q33987499-D4842A4F-A502-4997-8FCF-EA8835C04BA0Q34110804-4BEB9921-9F9D-4EC3-917A-157D0CBE448FQ34120884-60D2D41B-A534-4773-81BF-85481ACE8965Q34623840-CADF171F-39DD-4564-BBD7-2064D9ABED81Q34647087-B10ABC5B-904A-4EE4-AE98-AD428510A1E9Q34714730-5A4D0B9A-B5F0-4D97-854B-7168DA21F57FQ34786420-6A32B399-0012-4AD2-A3D9-16D24DAD5932Q34802752-FD57748E-43DA-4E31-9AD4-E86ADCB2AD7DQ34816447-247AEE8B-1E5E-4970-B634-D339A65AE657Q35010737-D3312A3A-09E6-4A1F-895A-043DDAE0A88DQ35012056-0CCF383F-31B4-4D97-9FA0-38C80AE4559EQ35033782-E3DAFE72-2160-4004-AF32-41420BBFDC33Q35101449-A5414260-B747-4F7D-AB22-9857CD7EF4AEQ35145409-5C26C9F6-FCA2-4163-806F-F8C6E9A14CE9
P2860
The human polyomavirus, JCV, uses serotonin receptors to infect cells
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The human polyomavirus, JCV, uses serotonin receptors to infect cells
@ast
The human polyomavirus, JCV, uses serotonin receptors to infect cells
@en
The human polyomavirus, JCV, uses serotonin receptors to infect cells
@nl
type
label
The human polyomavirus, JCV, uses serotonin receptors to infect cells
@ast
The human polyomavirus, JCV, uses serotonin receptors to infect cells
@en
The human polyomavirus, JCV, uses serotonin receptors to infect cells
@nl
prefLabel
The human polyomavirus, JCV, uses serotonin receptors to infect cells
@ast
The human polyomavirus, JCV, uses serotonin receptors to infect cells
@en
The human polyomavirus, JCV, uses serotonin receptors to infect cells
@nl
P2093
P3181
P356
P1433
P1476
The human polyomavirus, JCV, uses serotonin receptors to infect cells
@en
P2093
Aisling Dugan
Anushree Bhatnagar
Bryan L Roth
Gwendolyn F Elphick
Joslynn A Jordan
Kate Manley
Megan Stanifer
Sylvia Eash
Walter J Atwood
Wesley K Kroeze
P304
P3181
P356
10.1126/SCIENCE.1103492
P407
P577
2004-11-19T00:00:00Z